(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Dermapharm Holding SE, together with its subsidiaries, engages in the off-patent branded pharmaceuticals business in Germany and internationally. It operates through three segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts...
Stats | |
---|---|
今日成交量 | 38 113.00 |
平均成交量 | 20 397.00 |
市值 | 1.69B |
EPS | €0 ( 2024-03-27 ) |
下一个收益日期 | ( €0 ) 2024-05-13 |
Last Dividend | €1.050 ( 2023-06-15 ) |
Next Dividend | €0 ( N/A ) |
P/E | 17.78 |
ATR14 | €0.0750 (0.24%) |
音量 相关性
Dermapharm Holding SE 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Dermapharm Holding SE 相关性 - 货币/商品
Dermapharm Holding SE 财务报表
Annual | 2022 |
营收: | €1.02B |
毛利润: | €660.83M (64.49 %) |
EPS: | €2.49 |
FY | 2022 |
营收: | €1.02B |
毛利润: | €660.83M (64.49 %) |
EPS: | €2.49 |
FY | 2021 |
营收: | €942.91M |
毛利润: | €620.69M (65.83 %) |
EPS: | €3.89 |
FY | 2020 |
营收: | €793.83M |
毛利润: | €463.48M (58.39 %) |
EPS: | €1.590 |
Financial Reports:
No articles found.
Dermapharm Holding SE Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€1.050 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | €0.770 | 2019-06-05 |
Last Dividend | €1.050 | 2023-06-15 |
Next Dividend | €0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 5 | -- |
Total Paid Out | €5.67 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.23 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 7.09 | |
Div. Directional Score | 8.93 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SOW.DE | Ex Dividend Junior | 2023-05-18 | Annually | 0 | 0.00% | |
CRZK.DE | Ex Dividend Junior | 2023-07-17 | Annually | 0 | 0.00% | |
LLD.DE | Ex Dividend Junior | 2023-08-03 | Annually | 0 | 0.00% | |
1U1.DE | Ex Dividend Junior | 2023-05-17 | Annually | 0 | 0.00% | |
UWS.DE | Ex Dividend Knight | 2023-09-07 | Quarterly | 0 | 0.00% | |
EIN3.DE | Ex Dividend Knight | 2023-06-26 | Annually | 0 | 0.00% | |
NOVC.DE | Ex Dividend Junior | 2023-08-18 | Semi-Annually | 0 | 0.00% | |
ADS.F | Ex Dividend Junior | 2023-05-12 | Annually | 0 | 0.00% | |
GKS.DE | Ex Dividend Junior | 2023-06-29 | Sporadic | 0 | 0.00% | |
PSG.DE | Ex Dividend Knight | 2023-06-29 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0821 | 1.500 | 8.36 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0440 | 1.200 | 8.53 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.174 | 1.500 | 9.17 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.595 | -1.000 | 4.05 | -4.05 | [0 - 1] |
currentRatioTTM | 1.857 | 0.800 | 5.72 | 4.57 | [1 - 3] |
quickRatioTTM | 0.798 | 0.800 | -0.0114 | -0.00913 | [0.8 - 2.5] |
cashRatioTTM | 0.347 | 1.500 | 9.18 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.508 | -1.500 | 1.539 | -2.31 | [0 - 0.6] |
interestCoverageTTM | 4.32 | 1.000 | 9.51 | 9.51 | [3 - 30] |
operatingCashFlowPerShareTTM | 5.18 | 2.00 | 8.27 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 4.45 | 2.00 | 7.77 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 2.01 | -1.500 | 1.968 | -2.95 | [0 - 2.5] |
grossProfitMarginTTM | 0.642 | 1.000 | 2.64 | 2.64 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.192 | 1.000 | 8.15 | 8.15 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.254 | 1.000 | 9.70 | 9.70 | [0.2 - 2] |
assetTurnoverTTM | 0.536 | 0.800 | 9.76 | 7.81 | [0.5 - 2] |
Total Score | 10.77 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 17.75 | 1.000 | 8.31 | 0 | [1 - 100] |
returnOnEquityTTM | 0.174 | 2.50 | 9.47 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 4.45 | 2.00 | 8.52 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.35 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 5.18 | 2.00 | 8.27 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.595 | 1.500 | 4.05 | -4.05 | [0 - 1] |
pegRatioTTM | 13.67 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.241 | 1.000 | 6.48 | 0 | [0.1 - 0.5] |
Total Score | 7.09 |
Dermapharm Holding SE
Dermapharm Holding SE, together with its subsidiaries, engages in the off-patent branded pharmaceuticals business in Germany and internationally. It operates through three segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. The company develops, manufactures, licenses, markets, and sells branded generics, over-the-counter drugs, non-prescription natural remedies, and other healthcare products. It also offers healthcare products in the areas of vitamins, minerals, food supplements, dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology primarily under the Dekristol, Dekristolvit, Allergovit, and Tromcardin brands. In addition, the company provides medical devices under the bite away and Herpotherm names; Momekort, a nasal spray used to treat allergy symptoms; and Azedil, a nasal spray or eye drop. Further, it imports originator pharmaceuticals under the axicorp brand; and offers herbal extracts and natural active ingredients for phytopharmaceuticals, nutraceuticals, and cosmetics. It serves pharmaceutical wholesalers, pharmacies, hospitals, and health food stores. The company was founded in 1991 and is headquartered in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-Aktiengesellschaft.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。